Kidney Transplant Outcomes after Prolonged Delayed Graft Function

Background: The protracted recovery of renal function may be an actionable marker of post-transplant adverse events, but a paucity of data are available to determine if the duration of graft recovery serves to stratify risk. Materials and Methods: Single-center data of adult-isolated deceased-donor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2022-03, Vol.11 (6), p.1535
Hauptverfasser: Donnelly, Cullan V, Keller, Maria, Kayler, Liise
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page 1535
container_title Journal of clinical medicine
container_volume 11
creator Donnelly, Cullan V
Keller, Maria
Kayler, Liise
description Background: The protracted recovery of renal function may be an actionable marker of post-transplant adverse events, but a paucity of data are available to determine if the duration of graft recovery serves to stratify risk. Materials and Methods: Single-center data of adult-isolated deceased-donor kidney transplant (KTX) recipients between 1 July 2015 and 31 December 2018 were stratified by delayed graft function (DGF) duration, defined as time to serum creatinine < 3.0 mg/dL. Results: Of 355 kidney transplants, the time to creatinine < 3.0 mg/dL was 0−3 days among 96 cases (DGF ≤ 3), 4−10 days among 85 cases (DGF4-10), 11−20 days among 93 cases (DGF11-20), and ≥21 days for 81 cases (DGF ≥ 21). DGF ≥ 21 recipients were significantly more likely to be male, non-sensitized, and receive kidneys from donors that were older, with donation after circulatory death, non-mandatory share, hypertensive, higher KDPI, higher terminal creatinine, and longer cold and warm ischemia time. On multivariate analysis, DGF ≥ 21 was associated with a 5.73-fold increased odds of 12-month eGFR < 40 mL/min compared to DGF ≤ 3. Lesser degrees of DGF had similar outcomes. Conclusions: Prolonged DGF lasting over 20 days signifies a substantially higher risk for reduced eGFR at 1 year compared to lesser degrees of DGF, thus serving as a threshold indicator of increased risk.
doi_str_mv 10.3390/jcm11061535
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8954343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2642416602</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-b0c02d939733084efa46946b44194027cdb343db103d207458d0a469ee013833</originalsourceid><addsrcrecordid>eNpdkd1LwzAUxYMobsw9-S4FXwSp3jTpR16EMd0UB_Nh7yFN09nRJjNphf33pmyO6X25F-6PwzkchK4xPBDC4HEjG4whwTGJz9AwgjQNgWTk_OQeoLFzG_CTZTTC6SUakJhELEvwEE3eq0KrXbCyQrttLXQbLLtWmka5QJStssGHNbXRa1UEz6oWO7_n1n-CWadlWxl9hS5KUTs1PuwRWs1eVtPXcLGcv00ni1BSYG2Yg4SoYISlhEBGVSlowmiSU4oZhSiVRU4oKXIMpPDWaZwV0CNKAfYhyAg97WW3Xd6oQirdWlHzra0aYXfciIr__ejqk6_NN89YTL2yF7g7CFjz1SnX8qZyUtU-szKd41FCKWDMssijt__Qjems9ul6KqI4SaCn7veUtMY5q8qjGQy8L4eflOPpm1P_R_a3CvIDwZCIdA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2642416602</pqid></control><display><type>article</type><title>Kidney Transplant Outcomes after Prolonged Delayed Graft Function</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Donnelly, Cullan V ; Keller, Maria ; Kayler, Liise</creator><creatorcontrib>Donnelly, Cullan V ; Keller, Maria ; Kayler, Liise</creatorcontrib><description>Background: The protracted recovery of renal function may be an actionable marker of post-transplant adverse events, but a paucity of data are available to determine if the duration of graft recovery serves to stratify risk. Materials and Methods: Single-center data of adult-isolated deceased-donor kidney transplant (KTX) recipients between 1 July 2015 and 31 December 2018 were stratified by delayed graft function (DGF) duration, defined as time to serum creatinine &lt; 3.0 mg/dL. Results: Of 355 kidney transplants, the time to creatinine &lt; 3.0 mg/dL was 0−3 days among 96 cases (DGF ≤ 3), 4−10 days among 85 cases (DGF4-10), 11−20 days among 93 cases (DGF11-20), and ≥21 days for 81 cases (DGF ≥ 21). DGF ≥ 21 recipients were significantly more likely to be male, non-sensitized, and receive kidneys from donors that were older, with donation after circulatory death, non-mandatory share, hypertensive, higher KDPI, higher terminal creatinine, and longer cold and warm ischemia time. On multivariate analysis, DGF ≥ 21 was associated with a 5.73-fold increased odds of 12-month eGFR &lt; 40 mL/min compared to DGF ≤ 3. Lesser degrees of DGF had similar outcomes. Conclusions: Prolonged DGF lasting over 20 days signifies a substantially higher risk for reduced eGFR at 1 year compared to lesser degrees of DGF, thus serving as a threshold indicator of increased risk.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm11061535</identifier><identifier>PMID: 35329861</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Clinical medicine ; Creatinine ; Cytomegalovirus ; Ischemia ; Kidney diseases ; Kidney transplants</subject><ispartof>Journal of clinical medicine, 2022-03, Vol.11 (6), p.1535</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-b0c02d939733084efa46946b44194027cdb343db103d207458d0a469ee013833</citedby><cites>FETCH-LOGICAL-c409t-b0c02d939733084efa46946b44194027cdb343db103d207458d0a469ee013833</cites><orcidid>0000-0002-6370-6137</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954343/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954343/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35329861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Donnelly, Cullan V</creatorcontrib><creatorcontrib>Keller, Maria</creatorcontrib><creatorcontrib>Kayler, Liise</creatorcontrib><title>Kidney Transplant Outcomes after Prolonged Delayed Graft Function</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Background: The protracted recovery of renal function may be an actionable marker of post-transplant adverse events, but a paucity of data are available to determine if the duration of graft recovery serves to stratify risk. Materials and Methods: Single-center data of adult-isolated deceased-donor kidney transplant (KTX) recipients between 1 July 2015 and 31 December 2018 were stratified by delayed graft function (DGF) duration, defined as time to serum creatinine &lt; 3.0 mg/dL. Results: Of 355 kidney transplants, the time to creatinine &lt; 3.0 mg/dL was 0−3 days among 96 cases (DGF ≤ 3), 4−10 days among 85 cases (DGF4-10), 11−20 days among 93 cases (DGF11-20), and ≥21 days for 81 cases (DGF ≥ 21). DGF ≥ 21 recipients were significantly more likely to be male, non-sensitized, and receive kidneys from donors that were older, with donation after circulatory death, non-mandatory share, hypertensive, higher KDPI, higher terminal creatinine, and longer cold and warm ischemia time. On multivariate analysis, DGF ≥ 21 was associated with a 5.73-fold increased odds of 12-month eGFR &lt; 40 mL/min compared to DGF ≤ 3. Lesser degrees of DGF had similar outcomes. Conclusions: Prolonged DGF lasting over 20 days signifies a substantially higher risk for reduced eGFR at 1 year compared to lesser degrees of DGF, thus serving as a threshold indicator of increased risk.</description><subject>Clinical medicine</subject><subject>Creatinine</subject><subject>Cytomegalovirus</subject><subject>Ischemia</subject><subject>Kidney diseases</subject><subject>Kidney transplants</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkd1LwzAUxYMobsw9-S4FXwSp3jTpR16EMd0UB_Nh7yFN09nRJjNphf33pmyO6X25F-6PwzkchK4xPBDC4HEjG4whwTGJz9AwgjQNgWTk_OQeoLFzG_CTZTTC6SUakJhELEvwEE3eq0KrXbCyQrttLXQbLLtWmka5QJStssGHNbXRa1UEz6oWO7_n1n-CWadlWxl9hS5KUTs1PuwRWs1eVtPXcLGcv00ni1BSYG2Yg4SoYISlhEBGVSlowmiSU4oZhSiVRU4oKXIMpPDWaZwV0CNKAfYhyAg97WW3Xd6oQirdWlHzra0aYXfciIr__ejqk6_NN89YTL2yF7g7CFjz1SnX8qZyUtU-szKd41FCKWDMssijt__Qjems9ul6KqI4SaCn7veUtMY5q8qjGQy8L4eflOPpm1P_R_a3CvIDwZCIdA</recordid><startdate>20220311</startdate><enddate>20220311</enddate><creator>Donnelly, Cullan V</creator><creator>Keller, Maria</creator><creator>Kayler, Liise</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6370-6137</orcidid></search><sort><creationdate>20220311</creationdate><title>Kidney Transplant Outcomes after Prolonged Delayed Graft Function</title><author>Donnelly, Cullan V ; Keller, Maria ; Kayler, Liise</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-b0c02d939733084efa46946b44194027cdb343db103d207458d0a469ee013833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Clinical medicine</topic><topic>Creatinine</topic><topic>Cytomegalovirus</topic><topic>Ischemia</topic><topic>Kidney diseases</topic><topic>Kidney transplants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Donnelly, Cullan V</creatorcontrib><creatorcontrib>Keller, Maria</creatorcontrib><creatorcontrib>Kayler, Liise</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Donnelly, Cullan V</au><au>Keller, Maria</au><au>Kayler, Liise</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kidney Transplant Outcomes after Prolonged Delayed Graft Function</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2022-03-11</date><risdate>2022</risdate><volume>11</volume><issue>6</issue><spage>1535</spage><pages>1535-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Background: The protracted recovery of renal function may be an actionable marker of post-transplant adverse events, but a paucity of data are available to determine if the duration of graft recovery serves to stratify risk. Materials and Methods: Single-center data of adult-isolated deceased-donor kidney transplant (KTX) recipients between 1 July 2015 and 31 December 2018 were stratified by delayed graft function (DGF) duration, defined as time to serum creatinine &lt; 3.0 mg/dL. Results: Of 355 kidney transplants, the time to creatinine &lt; 3.0 mg/dL was 0−3 days among 96 cases (DGF ≤ 3), 4−10 days among 85 cases (DGF4-10), 11−20 days among 93 cases (DGF11-20), and ≥21 days for 81 cases (DGF ≥ 21). DGF ≥ 21 recipients were significantly more likely to be male, non-sensitized, and receive kidneys from donors that were older, with donation after circulatory death, non-mandatory share, hypertensive, higher KDPI, higher terminal creatinine, and longer cold and warm ischemia time. On multivariate analysis, DGF ≥ 21 was associated with a 5.73-fold increased odds of 12-month eGFR &lt; 40 mL/min compared to DGF ≤ 3. Lesser degrees of DGF had similar outcomes. Conclusions: Prolonged DGF lasting over 20 days signifies a substantially higher risk for reduced eGFR at 1 year compared to lesser degrees of DGF, thus serving as a threshold indicator of increased risk.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35329861</pmid><doi>10.3390/jcm11061535</doi><orcidid>https://orcid.org/0000-0002-6370-6137</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2022-03, Vol.11 (6), p.1535
issn 2077-0383
2077-0383
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8954343
source MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access
subjects Clinical medicine
Creatinine
Cytomegalovirus
Ischemia
Kidney diseases
Kidney transplants
title Kidney Transplant Outcomes after Prolonged Delayed Graft Function
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T23%3A11%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kidney%20Transplant%20Outcomes%20after%20Prolonged%20Delayed%20Graft%20Function&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Donnelly,%20Cullan%20V&rft.date=2022-03-11&rft.volume=11&rft.issue=6&rft.spage=1535&rft.pages=1535-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm11061535&rft_dat=%3Cproquest_pubme%3E2642416602%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2642416602&rft_id=info:pmid/35329861&rfr_iscdi=true